![]() Ablynx Ablynx is a biopharmaceutical company engaged in the development of Nanobodies, proprietary therapeutic proteins based on single-domain antibody fragments. | ![]() Promethera Biosciences Promethera Biosciences is a healthcare company developing cell therapy technologies for chronic liver diseases. | |||
Founding Date | Founding Date 2001 | Founding Date 2009 | Founding Date 1896 | Founding Date 2000 |
Type | Type Subsidiary | Type Subsidiary | Type Public | Type Public |
Tags | ||||
Locations | Locations Gent, BE HQ | Locations Mont-Saint-Guibert, BE HQ Charleroi, BE Ganshoren, BE Chuo City, JP Chuo City, JP Basel, CH Durham, US see more | Locations Amsterdam, NL HQ Villeurbanne, FR | |
Employees | Employees 1252% decrease | Employees 185% decrease | Employees 103,249 | Employees 133 |
Financial | ||||
Revenue (est.) | Revenue (est.) €85.2m (FY, 2016) | Revenue (est.) N/A | Revenue (est.) CHF61.5b (FY, 2025) | Revenue (est.) €11.8m (FY, 2018) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods CHF13.1b (FY, 2025) | Cost of goods €4.3m (FY, 2018) |
Gross profit | Gross profit N/A | Gross profit N/A | Gross profit CHF50.5b (FY, 2025) | Gross profit €7.5m (FY, 2018) |
Net income | Net income (€1.1m) (FY, 2016) | Net income N/A | Net income CHF13.8b (FY, 2025) | Net income (€18.5m) (FY, 2018) |
Funding | ||||
Total funding raised | Total funding raised $ 498.8m | Total funding raised $ 146m | Total funding raised $ 7.8b | Total funding raised N/A |

Promethera Biosciences is a healthcare company developing cell therapy technologies for chronic liver diseases.
View company
Roche Holding is a biotech company that provides in vitro diagnostics and supplies services.
View company
Esperite is a company specializing in regenerative and predictive medicine.
View company